We are happy to note that UALCAN (ualcan.path.uab.edu) has been cited over 2500 times now with over 1100 Citations last year. We thank all the users for their support. UAB Pathology, CCTS, UAB O'Neal Comprehensive Cancer Center, UAB Heersink School of Medicine, BCMHouston, #Cancer, @NCIgenomics, #TCGA

UALCAN (ualcan.path.uab.edu) now provides compendium of mass spectrometry-based proteomics data of over 2000 tumors, molecular subtypes and associated pathways UAB Pathology, UAB O'Neal Comprehensive Cancer Center, UAB Heersink School of Medicine, BCMHouston, @NCIDataSci, @NCIgenomics,University of Michigan, #Cancer, #TCGA, #CPTAC

Our new manuscript "Proteogenomic characterization of 2002 cancers" is online at Nature Communication nature.com/articles/s4146…. Data is integrated in to UALCAN (ualcan.path.uab.edu). UAB Pathology, UAB O'Neal Comprehensive Cancer Center, UAB Heersink School of Medicine, @NCIDataSci, @NCIgenomics, BCMHouston, #Cancer

Thrilled to see kind words for comprehensive and user-friendly #cancer data analysis portal, UALCAN (ualcan.path.uab.edu) from experts like Dr. Bradner! UAB Pathology, UAB Heersink School of Medicine, Dept of Biomedical Informatics and Data Science, UAB O'Neal Comprehensive Cancer Center, @NCIgenomics, @NCIDataSci, @NCIResearchCtr, NCI Cancer Control

Our study "ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors". Appeared in JCI Insight. insight.jci.org/articles/view/… JedUro1, Guru P. Sonpavde, MD, George J. Netto MD, UAB Heersink School of Medicine, UAB O'Neal Comprehensive Cancer Center, UAB Pathology, UAB Urology, Darshan Chandrashekar, #Cancer

UALCAN (ualcan.path.uab.edu), the integrative cancer data analysis portal reached 3,000 citations. We are thankful to all the users and suggestions UAB Pathology, UAB O'Neal Comprehensive Cancer Center, UAB Heersink School of Medicine, Dept of Biomedical Informatics and Data Science, @NCIgenomics, @NCIDataSci, BCMHouston, #Cancer, Yes! You All Can

UALCAN (ualcan.path.uab.edu) now provides list of potential #Cancer prognostic markers with Kaplan–Meier curves at :ualcan.path.uab.edu/analysis-surv.… UAB Pathology, @NCIDataSci , @NCIgenomics, UAB O'Neal Comprehensive Cancer Center, UAB Heersink School of Medicine, BCMHouston, ACS Research.

Our first study on EZH2 in cancer, published in Nature (2002) reached 3,000 citations today (2022). Many exciting investigations have been done on it during the last 20 years in various cancers and diseases now. It has got FDA approved inhibitor as well. #Cancer.

Received a kind note today "Thank you for developing UALCAN. I don't think my day goes by without visiting it at least once. UALCAN is extensively used in industries developing drug targets". Purpose is served when discoveries are made and #Cancer targets identified @NCIgenomics

We are extremely honored to note that we (ualcan.path.uab.edu) reached the landmark of a “Million” site visits. UAB Pathology, UAB O'Neal Comprehensive Cancer Center, Dept of Biomedical Informatics and Data Science, UAB Heersink School of Medicine, BCMHouston, @NCIgenomics, @NCIDataSci, American Cancer Society, #Cancer, #teamwork

We had a cake cutting to celebrate "Million" site visit for comprehensive #cancer data analysis platform UALCAN (ualcan.path.uab.edu) at the UAB Pathology department research retreat today. George J. Netto MD, Darshan Chandrashekar

UALCAN (ualcan.path.uab.edu) tops 1 million visits. uab.edu/news/research/… National Cancer Institute , @NCIgenomics, American Cancer Society, #TCGA, #CPTAC, #Cancer, #CancerResearch

Updates to UALCAN (ualcan.path.uab.edu), the comprehensive cancer "Omics" data analysis platform was presented at AACR Annual meeting today at Orlando. UAB Pathology, UAB O'Neal Comprehensive Cancer Center, UAB Heersink School of Medicine, Darshan Chandrashekar, Soory Varambally , George J. Netto MD , @NCIDataSci, @NCIgenomics, #Cancer

A perspective on using cancer proteomics to identify targets was published with our collaborators.lnkd.in/etKd_Pv4. The cancer data analysis platform UALCAN, ualcan.path.uab.edu provides the Clinical Proteomic Tumor Analysis Consortium data UAB Pathology, #Cancer

Our collaborative study "Global impact of somatic structural variation on the cancer proteome" is online @ nature.com/articles/s4146… Proteomics data are deposited in UALCAN platform @ ualcan.path.uab.edu, UAB Pathology, UAB O'Neal Comprehensive Cancer Center, UAB Heersink School of Medicine, BCMHouston, #Cancer

UALCAN (ualcan.path.uab.edu) analysis show that PD-L1 and IDO1, regulators of immune responses and therapeutic targets are increased and co-expressed in subtype of bladder cancers. Bladder Cancer Advocacy Network, #CancerResearch, @NCIgenomics, @NCIDataSci, UAB Pathology, #TCGA

UALCAN team is happy to release "UALCAN Mobile", a free app for analyzing #TCGA cancer gene expression data on the go. ualcan.path.uab.edu. UAB Pathology, UAB O'Neal Comprehensive Cancer Center, UAB Heersink School of Medicine, Dept of Biomedical Informatics and Data Science, BCMHouston, #CancerResearch @NCIDataSci, National Cancer Institute, @NCIgenomics

Thanks to the innovation of @uabpathology faculty Soory Varambally and Darshan Chandrashekar, cancer research is now mobile: The team has created a free mobile app based on their comprehensive cancer proteogenomic platform, UALCAN. bit.ly/40ZH4FR

UALCAN (ualcan.path.uab.edu) has been visited over 1.5 million times and cited over 6,000 times during last 8 years, enabling many discoveries. Thanks to collaborators and users for their kind support. UAB Pathology, UAB Heersink School of Medicine, National Cancer Institute, @NCIgenomics, @NCIDataSci, #Cancer

Preprint of our comprehensive breast cancer data analysis platform MammOnc-DB with over 20,000 breast cancer patient sample data (resource.path.uab.edu/MammOnc-Home.h……) is now online at: researchsquare.com/article/rs-492… UAB Pathology, UAB Heersink School of Medicine, National Cancer Institute, @NCIDataSci , @NCIgenomics , Breast Cancer Research Foundation of Alabama